Varian Associates (VAR) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Varian Associates (VAR)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: JakeStraw	1/12/2010 8:16:40 AM
	of 203

UK Cancer Network Implements Varian's ARIA(TM) for Electronic Prescribing and Comprehensive Electronic Patient Records finance.yahoo.com OXFORD, England, Jan. 12 /PRNewswire-FirstCall/ -- A chemotherapy software solution that enables patients to become more involved in managing their own care has been successfully rolled out across a network of hospitals in the UK. The Thames Valley Cancer Network has implemented Aria for Medical Oncology™ from Varian Medical Systems (NYSE: VAR) and already has more than 850 clinical staff routinely using the system. "The ARIA system has been extremely well received by clinical teams and patients alike," says Dr. Claire Blesing, consultant clinical oncologist at Churchill Hospital in Oxford and clinical lead for the project. "A big plus is that ARIA is not just a prescribing system, like the previous method we had here in Oxford, it's a full medical record. We were looking for something fresh and new to use in trusts that had no great background in electronic chemotherapy prescribing and ARIA gives us all the functionality we require."

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next